Rebecca Valentin

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

High Throughput

Acute Lymphoblastic Leukemia

Cell Cycle Arrest

Top Venues

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, Stephen J F Chong, Mary C Collins, Rebecca Valentin, Liam Hackett, Olivier Tournilhac, François Lemonnier, Jehan Dupuis, Adrien Daniel, Cecile Tomowiak, Kamel Laribi, Richard Greil, Damien Roosweil, Cédric Rossi, Eric Van Den Neste, Cecile Leyronnas, Fatiha Merabet, Jean Valère Malfuson, Mourad Tiab, Loïc Ysebaert, Samuel Ng, Judith Trotman, Philipp B Staber, Matthew S Davids
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia. Blood 137 (25) (2021)
Michael Asger Andersen, Rebecca Valentin, Lene Dissing Sjö, Line Borgwardt, Kjeld Schmiegelow, Mette Klarskov Andersen, Rasmus L Marvig, Christina Westmose Yde, Carsten Utoft Niemann
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Acta oncologica (Stockholm, Sweden) 59 (12) (2020)
Rebecca Valentin, Stephanie Grabow, Matthew S Davids
The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood 132 (12) (2018)